Volunteer in COVID-19 Oxford vaccine trial has died, Brazil health authority says

Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian.

Brazil health authority Anvisa said on Wednesday that trials of the COVID-19 vaccine developed by AstraZeneca and University of Oxford would continue after the death of volunteer involved in the tests.

Anvisa gave no further details on the death, citing confidentiality protocols. 

The story has been taken from a news agency